LXRX earnings call for the period ending June 30, 2020.
News & Analysis: Lexicon Pharmaceuticals
The biotech company reported better-than-expected first-quarter results and now sees lower costs in 2020.
LXRX earnings call for the period ending March 31, 2020.
LXRX earnings call for the period ending December 31, 2019.
Find out how an unexpected tragedy hit one of these stocks.
The FDA rebuffed the company's appeal for a failed new drug application. What happens now?
Despite doubts over its lead drug candidate and the loss of a major partner, the company is forging ahead.
LXRX earnings call for the period ending September 30, 2019.
Investors are jumping in ahead of a data presentation tomorrow.
The company will receive a big windfall for a terminated collaboration. What happens next?